Bioshares Biotech Clinical Trial (BBC)
$27.23 0.29 (1.05%)
20:00 EDT BBC Stock Quote Delayed 15 Minutes
Previous Close $27.23
Market Cap 62.62M
PE Ratio -
Volume (Avg. Vol.) 300
Day's Range 27.23 - 27.55
52-Week Range 20.22 - 35.54
Dividend & Yield 0.30 (1.09%)
BBC Stock Predictions, Articles, and Bioshares Biotech Clinical Trial News
- From InvestorPlace
- From the Web
Investors may tap these five ETFs for gains as President Trump aims the first shot in the trade war. Compare Brokers....
While P/E alone fails to identify a true value stock, PEG helps determine the intrinsic value of a stock. Compare Brokers....
Data support the notion that biotechnology stocks offer outperformance potential over diversified healthcare benchmarks. And these 5 biotech ETFs are a great to play the space.
Let's take a look Inside four heavily losing ETFs in the year-to-date frame.
Want to join biotech stocks on the industry's seemingly never-ending run higher? Consider these lesser-known biotech ETFs.
We can look for common issues that have appeared in the past before significant corrections, and from that perspective, biotechnology looks overheated.
The biotechnology story is one that continues to highlight evolving growth opportunities in the medical field.
The Inside ETFs Conference is one of the most interesting investment meetings of the year. Unlike other ETF industry gatherings, the Inside ETFs Conference, sponsored by website ETF.com, is the largest meet up in the business. With some 2,000 professional attendees all looking for the latest and greatest ways to use ETFs as part of their investment portfolios, this conference tends to generate buzz on the next wave of best ETF ideas.
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!